FR05C0045I2 - - Google Patents
Info
- Publication number
- FR05C0045I2 FR05C0045I2 FR05C0045C FR05C0045C FR05C0045I2 FR 05C0045 I2 FR05C0045 I2 FR 05C0045I2 FR 05C0045 C FR05C0045 C FR 05C0045C FR 05C0045 C FR05C0045 C FR 05C0045C FR 05C0045 I2 FR05C0045 I2 FR 05C0045I2
- Authority
- FR
- France
- Prior art keywords
- pct
- date sep
- sec
- pub
- antiobiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3329193A | 1993-03-12 | 1993-03-12 | |
PCT/US1994/001862 WO1994020505A1 (fr) | 1993-03-12 | 1994-03-07 | Acide libre cristallin de ceftiofur_______________________ |
Publications (2)
Publication Number | Publication Date |
---|---|
FR05C0045I1 FR05C0045I1 (fr) | 2006-01-06 |
FR05C0045I2 true FR05C0045I2 (fr) | 2007-08-03 |
Family
ID=21869579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR05C0045C Active FR05C0045I2 (fr) | 1993-03-12 | 2005-11-17 |
Country Status (31)
Country | Link |
---|---|
US (1) | US5721359A (fr) |
EP (1) | EP0690864B1 (fr) |
JP (1) | JP3852946B2 (fr) |
KR (1) | KR100296810B1 (fr) |
CN (1) | CN1055090C (fr) |
AT (1) | ATE202109T1 (fr) |
AU (1) | AU694419B2 (fr) |
BR (1) | BR1101034A (fr) |
CA (1) | CA2155322C (fr) |
CZ (1) | CZ289332B6 (fr) |
DE (2) | DE69427469T2 (fr) |
DK (1) | DK0690864T3 (fr) |
ES (1) | ES2157254T3 (fr) |
FI (1) | FI120307B (fr) |
FR (1) | FR05C0045I2 (fr) |
GR (1) | GR3036514T3 (fr) |
HU (1) | HU222244B1 (fr) |
IL (1) | IL108910A (fr) |
LU (1) | LU91206I2 (fr) |
LV (1) | LV12889B (fr) |
NL (1) | NL300208I2 (fr) |
NO (2) | NO313199B1 (fr) |
NZ (1) | NZ263002A (fr) |
PL (1) | PL184611B1 (fr) |
PT (1) | PT690864E (fr) |
RU (1) | RU2136685C1 (fr) |
SI (1) | SI0690864T1 (fr) |
SK (1) | SK283674B6 (fr) |
TW (1) | TW267170B (fr) |
WO (1) | WO1994020505A1 (fr) |
ZA (1) | ZA941586B (fr) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
US7829100B2 (en) * | 2000-09-12 | 2010-11-09 | Teagarden Dirk L | Pharmaceutical composition having modified carrier |
WO2002022107A2 (fr) * | 2000-09-12 | 2002-03-21 | Pharmacia & Upjohn Company | Composition pharmaceutique dotee d'un support modifie |
KR100423895B1 (ko) * | 2001-02-19 | 2004-03-24 | 주식회사 엘지생명과학 | 셉티오퍼 하이드로클로라이드의 현탁제 조성물 |
JP2005502628A (ja) * | 2001-07-10 | 2005-01-27 | ファルマシア・アンド・アップジョン・カンパニー | 結晶性チアジンオキサゾリジノン |
RS53251B (sr) * | 2001-08-15 | 2014-08-29 | Pharmacia & Upjohn Company Llc | Kristali koji sadrže n-[2-dietilamino)etil]-5-[(5-fluoro-2-okso-3h-indol-3-iliden)metil]-2,4-dimetil-1h-pirol-3- karboksamid so jabučne kiseline, procesi za njihovu pripremu i njihovi preparati |
ES2275092T5 (es) | 2002-03-21 | 2020-06-17 | Zoetis Services Llc | Procedimiento de administración de un antibiótico inyectable en la oreja de un animal |
US20040022815A1 (en) * | 2002-08-05 | 2004-02-05 | Orchid Health Care | Novel pharmaceutical composition of ceftiofur |
KR20040015622A (ko) * | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물 |
US20040115822A1 (en) * | 2002-09-12 | 2004-06-17 | Schapaugh Randal Lee | Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition |
US7659061B2 (en) | 2002-11-19 | 2010-02-09 | Pharmacia & Upjohn Company | Pharmaceutical compositions having a modified vehicle |
US20040115837A1 (en) * | 2002-11-27 | 2004-06-17 | Schapaugh Randal Lee | Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition |
US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
AU2004224181B2 (en) * | 2003-03-27 | 2011-06-02 | Basilea Pharmaceutica Ag | Cephalosporin in crystalline form |
RU2359670C2 (ru) | 2004-03-25 | 2009-06-27 | Астеллас Фарма Инк. | Композиция солифенацина или его соли для использования в твердом препарате |
US7815939B2 (en) | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
US8470809B2 (en) * | 2005-10-12 | 2013-06-25 | Orchid Chemicals & Pharmaceuticals Limited | Crystalline sodium salt of cephalosporin antibiotic |
JP2009511563A (ja) * | 2005-10-12 | 2009-03-19 | オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド | セファロスポリン抗生物質の結晶性ナトリウム塩 |
JP4691669B2 (ja) | 2007-08-22 | 2011-06-01 | アストラゼネカ・アクチエボラーグ | シクロプロピルアミド誘導体 |
WO2010036427A1 (fr) | 2008-06-17 | 2010-04-01 | Brigham Young University | Procédés de diagnostic, de détection, de tri et d'imagerie de stéroïdes cationiques antimicrobiens |
WO2010020871A2 (fr) * | 2008-08-22 | 2010-02-25 | Orchid Chemicals & Pharmaceuticals Limited | Sel de sodium cristallin de l'antibiotique céphalosporine |
KR101748890B1 (ko) * | 2008-11-19 | 2017-06-19 | 메리얼 인코포레이티드 | 세프티오퍼 및 케토프로펜 또는 세프티오퍼 및 벤질 알코올을 포함하는 제형 |
JP2012516344A (ja) * | 2009-01-30 | 2012-07-19 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 結晶質n−{(1s)−2−アミノ−1−[(3−フルオロフェニル)メチル]エチル}−5−クロロ−4−(4−クロロ−1−メチル−1h−ピラゾール−5−イル)−2−チオフェンカルボキサミド塩酸塩 |
TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
CN103140481A (zh) * | 2010-02-18 | 2013-06-05 | 阿斯利康(瑞典)有限公司 | 包含环丙基酰胺衍生物的固体形式 |
KR20130002316A (ko) | 2010-02-18 | 2013-01-07 | 아스트라제네카 아베 | 시클로프로필 벤즈아미드 유도체의 신규 결정질 형태 |
MX2013012820A (es) * | 2011-05-02 | 2014-02-10 | Zoetis Llc | Cefalosporinas novedosas utiles como agentes antibacteriales. |
WO2013013221A1 (fr) | 2011-07-20 | 2013-01-24 | Brigham Young University | Composés de céragénine hydrophobes et dispositifs incorporant ceux-ci |
EP2755661A1 (fr) | 2011-09-13 | 2014-07-23 | Brigham Young University | Compositions pour traiter les maladies osseuses et les fractures osseuses |
US9603859B2 (en) | 2011-09-13 | 2017-03-28 | Brigham Young University | Methods and products for increasing the rate of healing of tissue wounds |
US9694019B2 (en) | 2011-09-13 | 2017-07-04 | Brigham Young University | Compositions and methods for treating bone diseases and broken bones |
AU2012308530B2 (en) | 2011-09-13 | 2016-04-21 | Brigham Young University | Products for healing of tissue wounds |
EP3449900A1 (fr) | 2011-12-21 | 2019-03-06 | Brigham Young University | Compositions de protection orale |
CN102584855B (zh) * | 2012-02-16 | 2014-06-25 | 青岛科技大学 | 一种改进的头孢噻呋的制备方法 |
US9533063B1 (en) | 2012-03-01 | 2017-01-03 | Brigham Young University | Aerosols incorporating ceragenin compounds and methods of use thereof |
CA2872399C (fr) | 2012-05-02 | 2021-01-12 | Brigham Young University | Materiaux particulaires de ceragenine et leurs procedes de production |
CA2888259C (fr) | 2012-10-17 | 2019-05-28 | Brigham Young University | Traitement et prevention de la mastite |
JP6310396B2 (ja) * | 2012-12-03 | 2018-04-11 | 株式会社カネカ | 還元型補酵素q10誘導体およびその製造方法 |
US9943529B2 (en) | 2013-01-07 | 2018-04-17 | Brigham Young University | Methods for reducing cellular proliferation and treating certain diseases |
JP6518230B2 (ja) | 2013-03-15 | 2019-05-22 | ブリガム・ヤング・ユニバーシティBrigham Young University | 炎症、自己免疫疾患、および疼痛を治療する方法 |
US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
RU2546675C2 (ru) * | 2013-04-11 | 2015-04-10 | Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП") | Способ определения степени кристалличности составов на основе дифениламина |
US9387215B2 (en) | 2013-04-22 | 2016-07-12 | Brigham Young University | Animal feed including cationic cholesterol additive and related methods |
KR102460388B1 (ko) * | 2013-09-05 | 2022-10-27 | 미쓰비시 타나베 파마 코퍼레이션 | 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법 |
US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
CA2844321C (fr) | 2014-02-27 | 2021-03-16 | Brigham Young University | Composes antimicrobiens steroides cationiques |
US9867836B2 (en) | 2014-03-13 | 2018-01-16 | Brigham Young University | Lavage and/or infusion using CSA compounds for increasing fertility in a mammal |
US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
US9931350B2 (en) | 2014-03-14 | 2018-04-03 | Brigham Young University | Anti-infective and osteogenic compositions and methods of use |
US9686966B2 (en) | 2014-04-30 | 2017-06-27 | Brigham Young University | Methods and apparatus for cleaning or disinfecting a water delivery system |
US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
TN2017000157A1 (en) * | 2014-10-21 | 2018-10-19 | Ariad Pharma Inc | Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine |
WO2016172553A1 (fr) | 2015-04-22 | 2016-10-27 | Savage Paul B | Procédés de synthèse des céragénines |
US10370403B2 (en) | 2015-04-22 | 2019-08-06 | Brigham Young University | Methods for the synthesis of ceragenins |
KR101753842B1 (ko) * | 2015-05-12 | 2017-07-04 | 한국화학연구원 | 불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법 |
US9434759B1 (en) | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
CN106543203B (zh) * | 2015-09-18 | 2019-07-02 | 瑞普(天津)生物药业有限公司 | 一种长效头孢噻呋自由酸晶体的制备方法 |
AU2017208574B2 (en) * | 2016-01-22 | 2022-09-22 | Sandoz Ag | Crystalline eravacycline bis-hydrochloride |
US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
KR101898282B1 (ko) * | 2016-05-24 | 2018-09-13 | 주식회사 고려비엔피 | 항생제의 서방형 수의학적 조성물 및 이의 제조방법 |
JP2019524710A (ja) | 2016-07-07 | 2019-09-05 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | Sgc刺激剤の固体形態 |
US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
US11186556B1 (en) * | 2018-10-16 | 2021-11-30 | Celgene Corporation | Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof |
TW202233625A (zh) * | 2020-11-18 | 2022-09-01 | 美商傳達治療有限公司 | Fgfr抑制劑及其製造及使用方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1207933B (de) * | 1962-12-26 | 1965-12-30 | American Home Prod | Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin |
US3489752A (en) * | 1967-09-05 | 1970-01-13 | Bristol Myers Co | 7-amino-cephalosporanic and decephalosporanic acid derivatives |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
GB1532682A (en) * | 1976-04-27 | 1978-11-22 | Bristol Myers Co | Process for the preparation of cephadroxil |
FR2479229B1 (fr) * | 1980-03-26 | 1986-01-17 | Clin Midy | Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives |
IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
US4400503A (en) * | 1981-10-30 | 1983-08-23 | Eli Lilly And Company | Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid |
DE3313818A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
ES8702440A1 (es) * | 1984-10-04 | 1986-12-16 | Monsanto Co | Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa. |
IT1181672B (it) * | 1984-10-25 | 1987-09-30 | Upjohn Co | Cefalosporina alogenidrato cristallino |
US4902683A (en) * | 1984-10-25 | 1990-02-20 | The Upjohn Company | Crystalline cephalosporin hydrohalide salts |
JPH0749432B2 (ja) * | 1985-08-12 | 1995-05-31 | ジ・アップジョン・カンパニ− | セファロスポリンハロゲン化水素酸塩のアルカリ金属塩への変換 |
GB8608962D0 (en) * | 1986-04-12 | 1986-05-14 | Beecham Group Plc | Beta-lactam antibiotics |
IT1214587B (it) * | 1986-12-23 | 1990-01-18 | Giovanni Bonfanti | Metodo per la produzione diprodotti cristallini puri. |
DE3871542T2 (de) * | 1987-02-02 | 1992-12-24 | Lilly Co Eli | Verfahren zur herstellung von ceftazidime-pentahydrat. |
EP0386000B1 (fr) * | 1987-07-29 | 1992-03-11 | The Upjohn Company | Liberation commandee de sels antibiotiques a partir d'un implant |
US5134137A (en) * | 1987-11-10 | 1992-07-28 | The Upjohn Company | Cephalosporin antibiotics |
US4877782A (en) * | 1988-02-16 | 1989-10-31 | The Upjohn Company | Zinc ceftiofur complexes |
-
1994
- 1994-03-07 DE DE69427469T patent/DE69427469T2/de not_active Expired - Lifetime
- 1994-03-07 SI SI9430374T patent/SI0690864T1/xx unknown
- 1994-03-07 WO PCT/US1994/001862 patent/WO1994020505A1/fr active IP Right Grant
- 1994-03-07 ES ES94910721T patent/ES2157254T3/es not_active Expired - Lifetime
- 1994-03-07 JP JP52002594A patent/JP3852946B2/ja not_active Expired - Lifetime
- 1994-03-07 EP EP94910721A patent/EP0690864B1/fr not_active Expired - Lifetime
- 1994-03-07 PL PL94310556A patent/PL184611B1/pl unknown
- 1994-03-07 CA CA002155322A patent/CA2155322C/fr not_active Expired - Lifetime
- 1994-03-07 DE DE122005000055C patent/DE122005000055I2/de active Active
- 1994-03-07 SK SK1114-95A patent/SK283674B6/sk not_active IP Right Cessation
- 1994-03-07 KR KR1019950703858A patent/KR100296810B1/ko not_active IP Right Cessation
- 1994-03-07 CZ CZ19952290A patent/CZ289332B6/cs unknown
- 1994-03-07 CN CN94191448A patent/CN1055090C/zh not_active Expired - Lifetime
- 1994-03-07 AT AT94910721T patent/ATE202109T1/de active
- 1994-03-07 HU HU9501960A patent/HU222244B1/hu active Protection Beyond IP Right Term
- 1994-03-07 AU AU63510/94A patent/AU694419B2/en not_active Expired
- 1994-03-07 DK DK94910721T patent/DK0690864T3/da active
- 1994-03-07 RU RU95121942A patent/RU2136685C1/ru active
- 1994-03-07 NZ NZ263002A patent/NZ263002A/en not_active IP Right Cessation
- 1994-03-07 ZA ZA941586A patent/ZA941586B/xx unknown
- 1994-03-07 US US08/549,821 patent/US5721359A/en not_active Expired - Lifetime
- 1994-03-07 PT PT94910721T patent/PT690864E/pt unknown
- 1994-03-09 IL IL10891094A patent/IL108910A/en not_active IP Right Cessation
- 1994-03-12 TW TW083102155A patent/TW267170B/zh not_active IP Right Cessation
-
1995
- 1995-09-11 NO NO19953564A patent/NO313199B1/no not_active IP Right Cessation
- 1995-09-11 FI FI954250A patent/FI120307B/fi not_active IP Right Cessation
-
1997
- 1997-05-14 BR BR1101034-7A patent/BR1101034A/pt active IP Right Grant
-
2001
- 2001-09-04 GR GR20010401374T patent/GR3036514T3/el unknown
-
2002
- 2002-06-13 LV LVP-02-107A patent/LV12889B/lv unknown
-
2005
- 2005-11-16 LU LU91206C patent/LU91206I2/fr unknown
- 2005-11-17 FR FR05C0045C patent/FR05C0045I2/fr active Active
- 2005-11-18 NO NO2005025C patent/NO2005025I2/no unknown
- 2005-11-21 NL NL300208C patent/NL300208I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR05C0045I2 (fr) | ||
HUT72970A (en) | Risperidone pamoate, pharmaceutical composition containing it and process for their production | |
PL312739A1 (en) | New derivatives of perhydro isoindole, their production and pharmaceutical compounds containing them | |
PL310171A1 (en) | Novel imidazopyridines | |
IL124674A0 (en) | Piperazine derivatives pharmaceutical compositions containing the same and use thereof | |
HUT71584A (en) | Lipopeptide derivatives and pharmaceutical compositions containing them | |
HUT72594A (en) | New prednisolone derivative, process for its production, pharmaceutical composition containing the same | |
ZA922297B (en) | Crystalline tiababine monohydrate,its preparation and use | |
GB9126725D0 (en) | Process | |
AU1067295A (en) | Substituted aminoalkylaminopyridines | |
ES8606272A1 (es) | Procedimiento para preparar derivados carboxialquildipepti- dicos | |
AU681373B2 (en) | Process for preparing C-substituted diethylene triamines | |
IL117734A0 (en) | Beta-carbolines and pharmaceutical compositions containing them |